Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: Results of RTOG 94-12

International Journal of Radiation Oncology Biology Physics

Volumn 40, Issue 1, 1998, Pages 17-25

  Vijayakumar, Srinivasan ^a   Winter, Kathryn ^b   Sause, William ^c   Gallagher, Michael J ^d   Michalski, Jeff ^e   Roach, Mack ^f   Porter, Arthur ^g   Bondy, Melissa ^h  

^a UNIVERSITY OF CHICAGO   (United States)

^b AMERICAN COLLEGE OF RADIOLOGY   (United States)

^c Latter Day Saints Hospital   (United States)

^d Mercy Hospital   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g WAYNE STATE UNIVERSITY   (United States)

^h UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

African Americans; Prostate cancer; Prostate specific antigen; Race

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; HOUSEHOLD; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEGRO; PATIENT EDUCATION; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; SELF REPORT;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANALYSIS OF VARIANCE; EDUCATIONAL STATUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; INCOME; MALE; NEOPLASM STAGING; PROSPECTIVE STUDIES; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0031984026     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00834-1     Document Type: Article

References (18)

1. Andriole G. L. Serum prostate-specific antigen The most useful tumor marker . J. Clin. Oncol. 10:1992;1205-1207.
2. Stamey T. A., Yang N., Hay A. R., McNeal J. E., Freiha F. S., Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N. Engl. J. Med. 317:1987;909-916.
3. Asbell S. O., Vijayakumar S. Racial differences in prostate specific antigen levels in patients with local-regional prostate cancer. Prostate. 31:1997;42-46.
4. Moul J. W., Sesterhenn I. A., Connelly R. R., Douglas T., Srivastava S., Mostofi F. K., McLeod D. G. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA. 274:1995;1277-1281.
5. Teshima T., Hanlon A. M., Hanks G. E. Pretreatment prostate-specific antigen values in patients with prostate cancer 1989 Patterns of Care Study Process Survey . Int. J. Radiat. Oncol. Biol. Phys. 33:1995;809-814.
6. Vijayakumar S., Karrison T., Weichselbaum R. R., Chan S., Quadri S. F., Awan A. M. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. Cancer Epidemiol. Biomarkers Prev. 1:1992;541-545.
7. Vijayakumar S., Weichselbaum R., Vaida F., Dale W., Hellman S. Prostate-specific antigen levels in African-Americans correlate with insurance status as an indicator of socioeconomic status. Cancer J. Sci. Am. 2:1996;225-233.
8. Albertsen P. C. Commentary African-Americans and prostate cancer . Cancer J. Sci. Am. 2:1996;200-201.
9. Chybowski F. M., Keller J. J., Bergstralh E. J., Oesterling J. E. Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer prostate specific antigen is superior to all other clinical parameters . J. Urol. 145:1991;313-318.
10. Vijayakumar V., Vijayakumar S. Can prostate-specific antigen levels predict bone scan evidence of metastases in newly diagnosed prostate cancer Am . J. Clin. Oncol. 17:1994;432-436.
11. Fienberg S. E. The analysis of cross-classified categorical data. 2nd ed. 1980;95-119 MIT Press, Cambridge, MA.
12. Roach M., Krall J., Keller J. W., Perez C. A., Sause W. T., Doggett R. L., Rotman M., Russ H., Pilepich M. V., Asbell S. O., Shipley W. The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985). Int. J. Radiat. Oncol. Biol. Phys. 24:1992;441-449.
13. Black-white disparities in health care. JAMA. 263:1990;2344-2346.
14. Dale W., Vijayakumar S., Lawlor E., Merrell K. Prostate cancer, race, and socioeconomic status Inadequate adjustment for social factors in assessing racial differences . Prostate. 29:1996;271-281.
15. Ross R., Bernstein L., Judd H., Hanisch R., Pike M., Henderson B. Serum testosterone levels in healthy young black and white men. J. Natl. Cancer Inst. 76:1986;45-48.
16. Ross R. K., Bernstein L., Lobo R. A., Shimizu H., Stanczyk F. Z., Pike M. C., Henderson B. E. 5-alpha-reductase activity and risk of prostate cancer among Japanese and U.S. white and black males. Lancet. 339:1992;887-889.
17. Kantoff P. The x-chromosome files predicting deadly prostate cancer . Focus Newslett. Harvard Med. Dent. Public Health Schools June. 6:1996;1-2.
18. Vijayakumar S., Quadri S. F., Dong L., Ignacio L., Kathuria I. N. S., Sutton H., Halpern H. Results of a study to correlate serum prostate specific antigen and reproductive hormone levels in patients with localized prostate cancer. J. Nat. Med. Assoc. 87:1995;813-819.